MiniMed (MMED) Gross Margin (2025 - 2026)

MiniMed's (MMED) quarterly Gross Margin came in at 57.35% in Q2 2026, up 141.0% YoY from 23.8% in Q2 2025, and up 25.15% on a QoQ basis from 45.82% in Q1 2026.

MiniMed (MMED) Gross Margin (2025 - 2026) Analysis & Trends

MiniMed (MMED) has 2 years of Gross Margin data on file, last reported at 57.35% in Q2 2026.

  • Quarterly Gross Margin rose 141.0% year-over-year to 57.35% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 54.05% (changed N/A YoY) and the FY2026 annual result came in at 54.16%, down 212.0% from the prior year.
  • Gross Margin grew to 57.35% in Q2 2026, from 45.82% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 57.5% in Q1 2025 to a low of 45.82% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 74.98%
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 12.72%
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 72.27%
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 74.48%
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 86.44%
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 57.35%
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 69.44%
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 84.87%
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 83.00%
10 Privia Health 2.78 Bn 2.42 Bn - -

Historic Data

Download Data
DateValue
Apr 24, 2026 57.35%
Jan 23, 2026 45.82%
Apr 25, 2025 55.94%
Jan 24, 2025 57.50%